☰

Ramya K. Vadlapatla, Ph.D.

Affiliations: 
2014 Pharmaceutical Science University of Missouri - Kansas City, USA 
Area:
Pharmacy, Biochemistry
Google:
"Ramya Vadlapatla"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Ashim K. Mitra grad student 2014 University of Missouri - Kansas City
 (Ritonavir - A novel multidrug resistance modulator in cancer chemotherapy and ocular neovascular diseases.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vadlapatla RK, Pal D, Mitra AK. (2016) Uptake and Permeability Studies to Delineate the Role of Efflux Transporters. Methods in Molecular Biology (Clifton, N.J.). 1395: 69-74
Khurana V, Vadlapudi AD, Vadlapatla RK, et al. (2015) Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. Current Eye Research. 40: 457-69
Mitra A, Renukuntla J, Shah S, et al. (2015) Functional characterization and expression of folate receptor-α in T47D human breast cancer cells Drug Development and Therapeutics. 6: 52
Vadlapatla RK, Vadlapudi AD, Pal D, et al. (2014) Role of membrane transporters and metabolizing enzymes in ocular drug delivery. Current Drug Metabolism. 15: 680-93
Vadlapatla RK, Patel M, Paturi DK, et al. (2014) Clinically relevant drug-drug interactions between antiretrovirals and antifungals. Expert Opinion On Drug Metabolism & Toxicology. 10: 561-80
Kwatra D, Vadlapudi AD, Vadlapatla RK, et al. (2014) Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters. Drug Metabolism and Drug Interactions. 29: 101-10
Vadlapatla RK, Vadlapudi AD, Pal D, et al. (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (London, England). 28: 93-101
Vadlapudi AD, Cholkar K, Vadlapatla RK, et al. (2014) Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 30: 49-58
Vadlapatla RK. (2014) Ritonavir: A Powerful Boosting Agent for Overcoming Drug Resistance in Cancer Chemotherapy Journal of Cancer Science & Therapy. 6
Patel M, Mandava NK, Vadlapatla RK, et al. (2013) Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors. Pharmaceutical Patent Analyst. 2: 513-38
See more...